IS
ISLWF
Israel Acquisitions Corp
No data for this timeframe.
Vol
SEC Reports4
Recent Activity
May 15, 2026
SEC
Israel Acquisitions Corp filed a fifth amendment to its business combination agreement with Gadfin Ltd., extending the t
425 — Impact 3/10
May 15, 2026
SEC
Israel Acquisitions Corp filed a fifth amendment to its business combination agreement with Gadfin Ltd., extending the t
8-K — Impact 3/10
Apr 17, 2026
SEC
Israel Acquisitions Corp (ISLWF) filed a Rule 425 communication to disclose the fourth amendment to its business combina
425 — Impact 4/10
Latest Reports
NEUTRAL
425
3/10
Israel Acquisitions Corp filed a fifth amendment to its business combination agreement with Gadfin Ltd., extending the t
May 15, 2026
NEUTRAL
8-K
3/10
Israel Acquisitions Corp filed a fifth amendment to its business combination agreement with Gadfin Ltd., extending the t
May 15, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 4 neutral. Avg impact: 3.5/10.
NEUTRAL
425
3/10
Israel Acquisitions Corp filed a fifth amendment to its business combination agreement with Gadfin L
May 15, 2026
NEUTRAL
8-K
3/10
Israel Acquisitions Corp filed a fifth amendment to its business combination agreement with Gadfin L
May 15, 2026
NEUTRAL
425
4/10
Israel Acquisitions Corp (ISLWF) filed a Rule 425 communication to disclose the fourth amendment to
Apr 17, 2026
NEUTRAL
8-K
4/10
Israel Acquisitions Corp (ISLWF) extended the termination date of its business combination agreement
Apr 17, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.